Drops

The Bitcoin price has plummeted below the $39,000 mark, the lowest level since December 2. This significant drop can be attributed to three main factors that have collectively contributed to the current market…

After crypto exchange FTX and its trading arm Alameda Research filed for bankruptcy in November 2022, the failed company has been attempting to recover assets to refund its creditors. In a new development, the FTX affiliate has…

UK Retail Sales, GBP/USD AnalysisUK retail sales contracts at fastest monthly rate since the Covid affected period of January 2021Choppy GBP/USD price action remains undeterred – highlighting key horizontal levelsBank of England rate…

The introduction of Bitcoin (BTC) exchange-traded funds (ETFs) has triggered a significant sell-off, leading to a sharp decline in the Bitcoin price. After gaining approval and commencing trading on Thursday,…

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Former New Jersey governor Chris Christie has ended his campaign for president, in a move that was expected to…

Market Week Ahead: Gold Pops, US Dollar Drops, GBP/USD and EIR/USD RallyFor all market-moving economic data and events, see the DailyFX Calendar Recommended by Nick Cawley Building Confidence in Trading The US dollar…

COIN, MSTR, HOOD and crypto mining stocks MARA and RIOT are down today during pre-market hours while Bitcoin price is below $41,000. Today Bitcoin price is down. The major crypto asset is treading below $41,000 this morning. The main…

While Amazon did not provide the actual reason for not supporting Venmo as a payment option, the notable rise of web3 payment platforms could be a major factor. In October last year, Amazon.com Inc (NASDAQ: AMZN) announced that it would…

China’s consumer prices fell at the steepest pace in three years while producer costs dropped even further into negative territory, underscoring the challenges facing the economic recovery. The consumer price index fell 0.5% last month…

Pfizer Inc. is dropping development of an experimental weight-loss pill due to side effects, a blow to the drugmaker’s efforts to find new avenues for growth. More than half of patients in a mid-stage study had to stop taking twice-daily…